|
| Exchange Received Time 12/06/2017 19:21:03 Exchange Disseminated Time 12/06/2017 19:21:09 Time Taken 00:00:06 | We refer to our letter dated May 09, 2017 submitting Audited Financial Results (Standalone & Consolidated) for year ended 31-03-2017 along with 4th quarter results, Auditors report and the requisite declaration on unmodified opinion post our Board meeting. We hereby submit the revised Audited Financial Results (Standalone & Consolidated) with the following change
Reserves and surplus' (both standalone & consolidated) have increased by Rs. 323.30 million
Short-term provisions' (both standalone & consolidated) have decreased by Rs. 323.30 million
'Unallocated segment liabilities' (Note 1 - Consolidated financial statement) have decreased by Rs. 323.30 million
'Unallocated capital employed' (Note 1 - Consolidated financial statement) have increased by Rs. 323.30 million
There is no change in Profit and EPS numbers (both standalone and consolidated) reported in our financial results submitted to you earlier on May 9, 2017.
This is also available on our website at www.thyrocare.com.
|
|
|